Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Christian Seerup Frandsen"'
Autor:
Christian Stevns Hansen, Christian Seerup Frandsen, Jesper Fleischer, Dorte Vistisen, Jens Juul Holst, Lise Tarnow, Filip Krag Knop, Sten Madsbad, Henrik Ullits Andersen, Thomas Fremming Dejgaard
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
The role of the autonomic nervous system in the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 1 diabetes is unknown. We assessed the association between autonomic function and weight loss induced by the GLP-1
Externí odkaz:
https://doaj.org/article/9de8070814644870b0a0939aab535341
Autor:
Dorte Vistisen, Henrik U. Andersen, Kirsten Nørgaard, Jens-Erik Beck Jensen, Sten Madsbad, Sjudur Frodi Olsen, Thorhallur I. Halldorsson, Christian Seerup Frandsen, Thomas F. Dejgaard, Signe Schmidt
Publikováno v:
Schmidt, S, Frandsen, C S, Dejgaard, T F, Vistisen, D, Halldorsson, T, Olsen, S F, Jensen, J-E B, Madsbad, S, Andersen, H U & Nørgaard, K 2022, ' Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes ', Diabetes, Obesity and Metabolism, vol. 24, no. 2, pp. 212-220 . https://doi.org/10.1111/dom.14567
AimsTo present secondary outcome analyses of liraglutide treatment in overweight adults with insulin pump-treated type 1 diabetes (T1D), focusing on changes in body composition and dimensions, and to evaluate changes in food intake to identify potent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b120a58b8882580fa6a8d8d706b0a72f
https://doi.org/10.1111/dom.14567
https://doi.org/10.1111/dom.14567
Autor:
null Signe Schmidt, null Christian Seerup Frandsen, null Thomas Fremming Dejgaard, null Dorte Vistisen, null Thórhallur Halldórsson, null Sjudur Frodi Olsen, null Jens‐Erik Beck Jensen, null Sten Madsbad, null Henrik Ullits Andersen, null Kirsten Nørgaard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9e56883c7e9c4fcbf6afa516a89c286
https://doi.org/10.1111/dom.14567/v2/response1
https://doi.org/10.1111/dom.14567/v2/response1
Autor:
Maria Rubega, Christian Seerup Frandsen, Fabio Scarpa, Anne-Sophie Sejling, Debora Teodori, Giovanni Sparacino
Publikováno v:
Entropy
Volume 22
Issue 1
Entropy, Vol 22, Iss 1, p 81 (2020)
Volume 22
Issue 1
Entropy, Vol 22, Iss 1, p 81 (2020)
Previous literature has demonstrated that hypoglycemic events in patients with type 1 diabetes (T1D) are associated with measurable scalp electroencephalography (EEG) changes in power spectral density. In the present study, we used a dataset of 19-ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bce96641fb432f34232f06f9823ba8
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:947-960
Despite intensified insulin treatment, many persons with type 1 diabetes (T1D) do not achieve glycemic and metabolic targets. Consequently, non-insulin chemical therapies that improve glycemic control and metabolic parameters without increasing the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4dd5234f2e0f6cbf15d36f1702d0da
https://doi.org/10.1080/14656566.2018.1483339
https://doi.org/10.1080/14656566.2018.1483339
Autor:
Lise Tarnow, Sten Madsbad, Henrik U. Andersen, Ali Asmar, Thomas F. Dejgaard, Filip K. Knop, Christian Seerup Frandsen, Nanna B. Johansen
Publikováno v:
BASE-Bielefeld Academic Search Engine
Dejgaard, T F, Johansen, N B, Frandsen, C S, Asmar, A, Tarnow, L, Knop, F K, Madsbad, S & Andersen, H U 2017, ' Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes ', Diabetes, Obesity and Metabolism Online, vol. 19, no. 5, pp. 734-738 . https://doi.org/10.1111/dom.12841
Dejgaard, T F, Johansen, N B, Frandsen, C S, Asmar, A, Tarnow, L, Knop, F K, Madsbad, S & Andersen, H U 2017, ' Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes ', Diabetes, Obesity and Metabolism Online, vol. 19, no. 5, pp. 734-738 . https://doi.org/10.1111/dom.12841
We investigated the short-term effect of adding liraglutide 1.8 mg once daily to insulin treatment on cardiovascular risk factors in patients with type 1 diabetes. In total, 100 overweight (BMI ≥25 kg/m(2) ) adult patients (age ≥18 years) with ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5ef37c88dd7ab056d26b3259e8edf3
https://doi.org/10.1111/dom.12841
https://doi.org/10.1111/dom.12841
Autor:
Ulrik Pedersen-Bjergaard, Julie Lyng Forman, Sten Madsbad, Nicolai J. Wewer Albrechtsen, Thomas F. Dejgaard, Filip K. Knop, Christian Seerup Frandsen, Camilla Schlüntz, Jens J. Holst, Asger Lund, Henrik U. Andersen, Nicklas J. Johansen, Tina Vilsbøll
Publikováno v:
Ann Transl Med
Summary Background In type 2 diabetes, long-acting GLP-1 receptor agonists lower fasting plasma glucose and improve glycaemic control via their insulinotropic and glucagonostatic effects. In type 1 diabetes, their efficacy as an add-on treatment to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d616e336b946170f7834831531d111af
https://pubmed.ncbi.nlm.nih.gov/33437809
https://pubmed.ncbi.nlm.nih.gov/33437809
Autor:
Thure Krarup, Jens J. Holst, Thomas F. Dejgaard, Christian Seerup Frandsen, Henrik U. Andersen, Sten Madsbad, Birger Thorsteinsson, Urd Kielgast
Publikováno v:
Diabetes. 68
Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion in adults with type 1 diabetes and residual beta-cell function. This randomized, double-blind, placebo-controlled, 52-week trial evaluated the efficacy of liraglutide 1.8 mg QD added to ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8974dd31a768f064d72f73c693f4a69
https://doi.org/10.2337/db19-59-or
https://doi.org/10.2337/db19-59-or
Autor:
Christian Torp-Pedersen, Lars Køber, Emil L. Fosbøl, Ulrik M. Mogensen, Nana Valeur Køber, Andrew Wang, Christian Seerup Frandsen, Lauge Østergaard, Gunnar Gislason, Anders Dahl, Johan S Bundgaard, Thomas F. Dejgaard
Publikováno v:
Østergaard, L, Mogensen, U M, Bundgaard, J S, Dahl, A, Wang, A, Torp-Pedersen, C, Gislason, G, Køber, L, Køber, N, Dejgaard, T F, Frandsen, C S & Fosbøl, E L 2019, ' Duration and complications of diabetes mellitus and the associated risk of infective endocarditis ', International Journal of Cardiology, vol. 278, pp. 280-284 . https://doi.org/10.1016/j.ijcard.2018.09.106
Background Long duration of diabetes mellitus (DM) is associated with an increased risk of infection, however no studies have yet focused on the duration of DM and the associated risk of infective endocarditis (IE). Methods Patients with DM were iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09814c4926592cb776d2d2b7bca176e3
https://vbn.aau.dk/da/publications/142df391-503f-48a7-91dd-eea1d1b6632b
https://vbn.aau.dk/da/publications/142df391-503f-48a7-91dd-eea1d1b6632b
Publikováno v:
The Lancet Diabetes & Endocrinology. 4:766-780
Summary Insulin treatment of individuals with type 1 diabetes has shortcomings and many patients do not achieve glycaemic and metabolic targets. Consequently, the focus is on novel non-insulin therapeutic approaches that reduce hyperglycaemia and imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::343adb01aa6d164900b6f7348d565e20
https://doi.org/10.1016/s2213-8587(16)00039-5
https://doi.org/10.1016/s2213-8587(16)00039-5